Los Angeles Capital Management’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-1,277
Closed -$207K 1494
2021
Q2
$207K Buy
+1,277
New +$207K ﹤0.01% 1489